It’s a good day for the folks at TransS1. The company has pulled off a successful IPO, with the stock price surging more than 60%.
What’s even more impressive is that the company is in a sector that’s out-of-favor: healthcare.
So what makes TranS1 different?
Well, the company certainly has strong technology (medical devices to help with back surgery). And the management team is strong.
But it’s also crucial that the company has been focused on getting market adoption for its innovations.
And one useful strategy is training. This is how TranS1 explains it (from the prospectus):
“We devote significant resources to training and educating surgeons on the specialized skills involved in the proper use of our instruments and implants. We believe that the most effective way to introduce and build market demand for our products is by training spine surgeons in the use of our products. We accomplish our training objectives primarily through cadaver and surrogate models and live case observations with surgeons experienced in our TranS1 approach. After this training, surgeons are generally able to perform unsupervised surgeries using our TranS1 approach. We supplement our training with online didactic tutorials. As of June 30, 2007, we had trained approximately 500 U.S. spine surgeons and 54 surgeons outside of the U.S. in the use of our products. Of the surgeons trained on our TranS1 approach, approximately 190 have performed a procedure in the 12 months ended June 30, 2007 using our TranS1 approach. We believe we have the necessary capacity to train a sufficient number of surgeons to meet our current goals.”
Also, to check out other IPOs, click here.
Filed under: IPOs, Marketing | Leave a comment »